Canadian biotech Aspect Biosystems, which is developing bioprinted tissue therapeutics as a new category in regenerative ...

Insilico Medicine raises over $100 million in series E funding to advance AI-driven drug discovery, including ISM001-055, the ...

Calico Life Sciences, a biotech founded by Alphabet and Arthur Levinson focused on the biology of aging and age-related ...

Galapagos plans to split into two entities by mid-2025, focusing its core business on cell therapies while spinning off a new ...

Antag Therapeutics, a Denmark-based biopharma developing novel treatments for obesity, has announced the appointment of Joerg ...

Denmark’s Novo Nordisk and Valo Health today announced they have entered into an expanded agreement to discover and develop ...

Privately-held US biotech Alloy Therapeutics has announced a target specific collaboration and license agreement for the use ...

Vertex Pharmaceuticals and Orna Therapeutics announce a $4 billion collaboration to develop in vivo gene editing therapies ...

Californian oncology-focused biotech Avenzo Therapeutics and China-based Duality Biotherapeutics (DualityBio) have entered ...

The US Food and Drug Administration has imposed a label change for two new respiratory syncytial virus (RSV) vaccine rivals.

Johnson & Johnson's Rybrevant and Lazcluze combination shows significant overall survival benefits over Tagrisso in the ...

Capsida Biotherapeutics yesterday revealed US pharma major AbbVie has exercised an option for the first neurodegenerative ...